Back to Companies
Scribe Therapeutics, Inc.
SCTXNasdaqCIK: 0001853921
Over the 25 most recent insider filings, Scribe Therapeutics, Inc. (SCTX) has seen activity from 12 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $71.3M bought versus $0 sold, a net purchase of $71.3M. Aghazadeh Behzad (Director, 10% Owner) is the most active by dollar volume, and the single largest transaction was $36.3M by Aghazadeh Behzad. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$90.5M
Purchases
$71.3M
Sales
$0
Unique Insiders
12
Recent Insider Trades
25 loaded
| Jul 29 | SCTX Scribe Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director | Buy | $15.0M |
| Jul 29 | SCTX Scribe Therapeutics, Inc. | Doudna Jennifer A | Insider | Conversion | $0 |
| Jul 29 | SCTX Scribe Therapeutics, Inc. | AH Bio Fund II, L.P. | Insider | Buy | $5.0M |
| Jul 28 | SCTX Scribe Therapeutics, Inc. | Aghazadeh Behzad | Director, 10% Owner | Buy | $36.3M |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | GORDON CARL L | Insider | Other | $0 |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | Parrot David | Insider | Other | $0 |
| Jul 27 | SCTX Scribe Therapeutics, Inc. | Watson James Dean | Insider | Award | $220.9K |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | Aghazadeh Behzad | Director | Other | $0 |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | Watson James Dean | Insider | Other | $0 |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | Doudna Jennifer A | Insider | Other | $0 |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | ELI LILLY & Co | Insider | Other | $0 |
| Jul 27 | SCTX Scribe Therapeutics, Inc. | Aghazadeh Behzad | Director | Award | $220.9K |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director | Other | $0 |
| Jul 27 | SCTX Scribe Therapeutics, Inc. | Bleharski Joshua | Insider | Award | $220.9K |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | Staahl Brett | Insider | Other | $0 |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | Oakes Benjamin L. | Insider | Other | $0 |
| Jul 27 | SCTX Scribe Therapeutics, Inc. | GORDON CARL L | Insider | Award | $220.9K |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | Lucas Svetlana | Insider | Other | $0 |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | AH Bio Fund II, L.P. | Insider | Other | $0 |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | Bleharski Joshua | Insider | Other | $0 |
| Jul 29 | SCTX Scribe Therapeutics, Inc. | GORDON CARL L | Director | Buy | $15.0M |
| Jul 27 | SCTX Scribe Therapeutics, Inc. | Parrot David | Insider | Buy | $40.0K |
| Jul 28 | SCTX Scribe Therapeutics, Inc. | Staahl Brett | Insider | Award | $672.5K |
| Jul 27 | SCTX Scribe Therapeutics, Inc. | Lucas Svetlana | Insider | Buy | $45.0K |
| Jul 27 | SCTX Scribe Therapeutics, Inc. | Oakes Benjamin L. | Insider | Award | $10.7M |
25 filings